MARA up +4.55% percent Today $MARA High is at 15.90 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 2:02 PM

MARA up +4.55% percent Today $MARA High is at 15.90 and the Low 14.91 with current volume of 75,197.

Recent News posted below.

Marathon Patent Group Inc. MARA other info.
http://investorshangout.com/Marathon-Patent-G...ARA-69068/

MARA Marathon Patent Group Inc. Recent Headline News

Update: Marathon Patent Group Reports Outstanding Q3 Revenues And Earnings
Mobile Guru - at Seeking Alpha - Thu Nov 13, 6:20AM CST

ACTG: 18.76 (unch), MARA: 14.34 (-0.16)

Marathon Patent EPS of $1.20
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:43PM CST

MARA: 14.34 (-0.16)

Marathon Patent Group, Inc. Announces Strong Third Quarter 2014 Financial Results
Marketwired - Wed Nov 12, 3:06PM CST
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon" or the "Company"

, a patent licensing company, announced today financial results for the third quarter ended September 30, 2014. Highlights included:
MARA: 14.34 (-0.16)

Marathon Patent Group Names Chief Technology Officer / Senior Vice President of Licensing and Senior Vice President of Licensing
Marketwired - Mon Nov 10, 12:03PM CST
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that Umesh Jani and Rick Sanchez have been named to the Company's Executive Management Team as Chief Technology Officer / SVP of Licensing and Senior Vice President of Licensing, respectively.
MARA: 14.34 (-0.16)

Marathon Patent Group, Inc. to Announce Third Quarter 2014 Financial Results on November 12, 2014
Marketwired - Wed Nov 05, 8:01AM CST
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that the Company will issue financial results for the third quarter ended September 30, 2014 after the market closes on Wednesday, November 12, 2014.
MARA: 14.34 (-0.16)

Marathon Patent Group Recently Acquired MedTech Patents Already Paying Dividends
Mobile Guru - at Seeking Alpha - Wed Nov 05, 7:31AM CST

MARA: 14.34 (-0.16)

Marathon Patent Group Wholly Owned Subsidiary MedTech Development Deutschland GmbH Receives Favorable First Instance Patent Infringement Ruling Against Stryker GmbH & Co. KG
Marketwired - Mon Nov 03, 10:20AM CST
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that on October 30, 2014, Marathon Patent Group wholly owned subsidiary MedTech Development Deutschland GmbH was notified that two favorable first instance patent infringement rulings have been issued involving the German parts of European patent EP 1 938 765 B1 and EP 1 104 260 B2 ('patents in dispute'

before the Duesseldorf District Court. The rulings include injunctive relief and damages, as well as the additional grant of claims for destruction of the infringing products and information on the distribution chain. Formal notification of the ruling is expected shortly.
MARA: 14.34 (-0.16)

Judge Issues Order in TLI Communications LLC Patent Litigation
Marketwired - Mon Oct 27, 7:31AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that on October 16, 2014, Honorable United States District Judge T.S. Ellis, III, issued an order relating to all member cases in the TLI Communications LLC patent litigation.
MARA: 14.34 (-0.16)

Marathon Patent Group's Wholly-Owned Subsidiary Vantage Point Technology Inc. Files Patent Infringement Lawsuits Against Apple, Amazon, Box, Dropbox, Google and SugarSync
Marketwired - Wed Oct 22, 12:13PM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that its wholly-owned subsidiary Vantage Point Technology Inc. ("Vantage Point"

, has filed patent infringement lawsuits against Amazon.com Inc., Apple, Inc., Box, Inc., Dropbox, Inc., Google Inc., and SugarSync, Inc. in the United States District Court for the Eastern District of Texas.
AMZN: 315.42 (+3.91), MARA: 14.34 (-0.16), GOOGL: 555.78 (-2.47), AAPL: 112.51 (+1.26)

White House nominates ex-Google patent counsel to head USPTO
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 1:24PM CDT

VRNG: 0.93 (-0.02), WILN: 3.38 (-0.02), ACTG: 18.76 (unch), MARA: 14.34 (-0.16), CRDS: 2.52 (-0.11), FNJN: 2.63 (-0.32), DSS: 0.51 (+0.04), VHC: 5.02 (+0.01)

Marathon Patent Group Completes Major Transaction for Significant Patent Assets and Accepts Subscriptions for $5.5 Million Financing
Marketwired - Mon Oct 13, 7:31AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) On October 10, 2014, Marathon Patent Group, Inc. ("Marathon"

entered into an interest sale agreement with MedTech Development, LLC. Pursuant to the Interest Sale Agreement, Marathon agreed to acquire from MedTech certain subsidiaries of MedTech consisting of 100% of the limited liability membership interests of OrthoPhoenix, LLC and TLIF, LLC as well as 100% of the shares of MedTech Development Deutschland GmbH. As a result, Marathon became the sole interest holder of OrthoPhoenix and TLIF as well as the sole shareholder and owner of MedTech GmbH. Each of the Subsidiaries owns certain medical technology patents, including pending litigation and settlement and licensing rights that are being acquired by the Company in the transaction.
MARA: 14.34 (-0.16)

CORRECTION - Marathon Patent Group Acquires TLI Communications LLC
Marketwire - Thu Sep 25, 10:08AM CDT
In the news release, "Marathon Patent Group Acquires TLI Communications LLC," issued earlier today by Marathon Patent Group (NASDAQ: MARA), we are advised by the company that the patent number in the first paragraph should read "6,038,295" rather than "6,3038,295" as originally issued. Complete corrected text follows.
MARA: 14.34 (-0.16)

Marathon Patent Group Acquires TLI Communications LLC
Marketwire - Thu Sep 25, 7:30AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that it has acquired TLI Communications LLC., owner of U.S. patent No. 6,3038,295 ('295 patent), which is an apparatus and method for recording, communicating and administering digital images.
FB: 74.13 (-0.59), MARA: 14.34 (-0.16)

Marathon Patent Group Receives Updated Analysis in New Report
Marketwire - Tue Sep 16, 11:50AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA), a patent licensing company, announced the commercial launch of its Opus Patent Analysis Platform this week. Marathon has received plenty of attention recently, and today, John H. Ford, who's been an active investor in the intellectual property space since he first invested in VirnetX four years ago, added to the growing interest with his update at Seeking Alpha.
MARA: 14.34 (-0.16)

Marathon Patent Group Names Daniel Gelbtuch Chief Marketing Officer
Marketwire - Tue Sep 16, 8:03AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that it has named Daniel Gelbtuch as its Chief Marketing Officer.
MARA: 14.34 (-0.16)

Marathon Announces Launch of Opus Patent Analysis Platform
Marketwire - Mon Sep 15, 8:01AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today the commercial launch of the Opus(TM) Patent Analysis Platform.
MARA: 14.34 (-0.16)

Marathon Patent Group Announces That USPTO Has Denied Arm Inc. Petition for Inter Partes Review of Vantage Point Patent
Marketwire - Mon Sep 08, 8:03AM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"

, a patent licensing company, announced today that on September 5, 2014, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) denied a petition for inter partes review (IPR) filed by Arm Inc. against Marathon subsidiary Vantage Point Technology's U.S. Patent No. 5,463,750 ('750 patent).
MARA: 14.34 (-0.16)

Marathon Patent Group, Inc. Announces Participation in Upcoming Investor Conferences
Marketwire - Thu Aug 28, 3:01PM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA), a patent licensing company, announced today that the Company will participate in two upcoming investor conferences. The conference details are as follows:
MARA: 14.34 (-0.16)

Marathon Patent Group, Inc. Announces Second Quarter 2014 Financial Results
Marketwire - Thu Aug 14, 3:02PM CDT
Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon" or "The Company"

, a patent licensing company, announced today financial results for the second quarter ended June 30, 2014. Highlights included:
MARA: 14.34 (-0.16)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

PZZA Faces Class Action: Strategic Shake-up or Misstep?

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Pathalys' Phase 3 Data Shows Promise for CKD Drug

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

DigitalXForce Booms with 514% Growth and Major Backing

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...